Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
This was 8 months ago
LocationWallonia Conference Center Mons (WCCM)
The Marie Skłodowska-Curie Actions (MSCA) Presidency Conference 2024 will explore the multiple pathways of researchers' careers. It is organised under the Belgian presidency of the Council of the European Union in cooperation with the European Commission. This two-day event will take place on 18 and 19 April 2024 in Mons/Bergen, at the Wallonia Conference Center. What can you expect?
This event, co-created by the Walloon Region, the Fédération Wallonie-Bruxelles, the Flemish Government (EWI) and BELSPO in partnership with the European Commission, is a unique opportunity to contribute to the European Research Area (ERA) together.
For all information on the event and to stay up to date, please visit the event website. Registration for the conference is open. There is an early bird discount on hotel bookings (details under 'practical').
#MSCA2024BE
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security AI, data & cloud Cybersecurity Defence Space
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.